(NYSE: CBT) Cabot's forecast annual revenue growth rate of 2.1% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.1%.
Cabot's revenue in 2026 is $3,607,000,000.On average, 7 Wall Street analysts forecast CBT's revenue for 2026 to be $188,258,882,420, with the lowest CBT revenue forecast at $176,979,015,956, and the highest CBT revenue forecast at $202,045,385,876. On average, 7 Wall Street analysts forecast CBT's revenue for 2027 to be $193,794,372,444, with the lowest CBT revenue forecast at $182,566,727,584, and the highest CBT revenue forecast at $207,058,659,860.
In 2028, CBT is forecast to generate $200,739,845,776 in revenue, with the lowest revenue forecast at $189,146,649,688 and the highest revenue forecast at $215,779,667,728.